Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2465-2469

  Foulkes, William D ^a,b   Wong, Nora ^a,b   Brunet, Jean Sebastien ^c   Bégin, Louis R ^a   Zhang, Jian Chun ^a   Martinez, John J ^d   Rozen, Florence ^a   Tonin, Patricia N ^b   Narod, Steven A ^c   Karp, Stephen E ^a,e   Pollak, Michael N ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SURVIVAL; FEMALE; GENE MUTATION; HUMAN; JEW; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HETEROZYGOTE DETECTION; HUMANS; JEWS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; SEQUENCE DELETION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0031408437     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., and Brody, L. C. The carrier frequency of the BRCA1 185delAG mutation is approximately 1% in Ashkenazi Jewish individuals. Nat. Genet., 11: 198-200, 1995.
2. Roa, B. B., Boyd, A. A., Volcik, K., and Richards, C. S. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat. Genet., 14: 185-187, 1996.
3. FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., Sgroi, D. C., Smith, B. L., Younger, J. W., Garber, J. E., Duda, R. B., Mayzel, K. A., Isselbacher, K. J., Friend, S. H., and Haber, D. A. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N. Engl. J. Med., 334: 143-149, 1996.
4. Offit, K., Gilewski, T., McGuire, P., Schluger, A., Hampel, H., Brown, K., Swensen, J., Neuhausen, S., Skolnick, M., Norton, L., and Goldgar, D. Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet, 347: 1643-1645, 1996.
5. Tonin, P., Weber, B., Offit, K., Couch, F., Rebbeck, T. R., Neuhausen, S., Godwin, A. K., Daly, M., Wagner-Costalas, J., Berman, D., Grana, G., Fox, E., Kane, M. F., Kolodner, R. D., Krainer, M., Haber, D. A., Struewing, J. P., Warner, E., Rosen, B., Lerman, C., Peshkin, B., Norton, L., Serova, O., Foulkes, W. D., Lynch, H. T., Lenoir, G. M., Narod, S. A., and Garber, J. E. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat. Med., 2: 1183-1196, 1996.
6. Easton, D., Ford, D., and Peto, J. Inherited susceptibility to breast cancer. Cancer Surv., 18: 95-113, 1993.
7. Friedman, L. S., Szabo, C. I., Ostermeyer, E. A., Dowd, P., Butler, L., Park, T., Lee, M. K., Goode, E. L., Rowell, S. E., and King, M. C. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am. J. Hum. Genet., 57: 1284-1297, 1995.
8. Abeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., Zlotogora, J., Heching, N., and Peretz, T. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet., 60: 505-514, 1997.
9. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Söderkuist, P., Terry, L., Jhanwar, S., Berchuk, A., Inglehart, J. D., Marks, J., Ballinger, P. G., Barrett, J. C., Skolnick, M. H., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
10. Neuhausen, S., Gilewski, T., Norton, L., Tran, T., McGuire, P., Swensen, J., Hampel, H., Borgen, P., Brown, K., Skolnick, M., Shattuck-Eidens, D., Jhanwar, S., Goldgar, D., and Offit, K. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat. Genet., 13: 126-128, 1996.
11. Phelan, C. M., Lancaster, J. M., Tonin, P., Gumbs, C., Cochran, C., Carter, R., Ghadirian, P., Perret, C., Moslehi, R., Dion, F., Faucher, M. C., Dole, K., Karimi, S., Foulkes, W., Lounis, H., Warner, E., Goss, P., Anderson, D., Larsson, C., Narod, S. A., and Futreal, P. A. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet., 13: 120-122, 1996.
12. Page, D. L. The epidemiology of tumor markers in breast cancer management: prognostic markers. Cancer Epidemiol. Biomarkers Prev., 3: 101-104, 1994.
13. Carter, C. L., Allen, C., and Henson, D. E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer (Phila.), 63: 181-187, 1989.
14. Albain, K. S., Allred, D. C., and Clark, G. M. Breast cancer outcome and predictors of outcome: are there age differentials? Monogr. Natl. Cancer Inst., 16: 35-42, 1994.
15. Byrne, C., Smart, C. R., Chu, K. C., and Hartmann, W. H. Survival advantage differences by age. Cancer (Phila.), 74: 301-310, 1994.
16. Swanson, G. M., and Lin, C. Survival patterns among younger women with breast cancer: the effects of age, race, stage and treatment. Monogr. Natl. Cancer Inst., 16: 69-77, 1994.
17. Porter, D. E., Cohen, B. B., Wallace, M. R., Smyth, E., Chetty, U., Dixon, J. M., Steel, C. M., and Carter, D. C. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br. J. Surg., 81: 1512-1515, 1994.
18. Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., and Lynch, H. T. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (Phila.), 77: 697-709, 1996.